Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.

Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
复制标题

DOI:
10.1016/j.ejmech.2008.09.013
复制
发表时间:
2009-03
影响因子:
6.7
通讯作者:
Cushman, Mark
Cushman, Mark
中科院分区:
医学1区
文献类型:
--
作者:
Deng, Bo-Liang;Zhao, Yujie;Hartman, Tracy L.;Watson, Karen;Buckheit, Robert W., Jr.;Pannecouque, Christophe;De Clercq, Erik;Cushman, Mark

文献摘要

参考文献

被引文献

相似文献

As a continuation of efforts to replace the metabolically labile methyl esters of the lead alkenyldiarylmethanes (ADAMs) with stable bioisosteres, compounds bearing benzo[d]isoxazole and oxazolidine-2-one rings were designed and evaluated as a new series of potent HIV-1 non-nucleoside reverse transcriptase inhibitors with anti-HIV activity. All of the resulting ADAMs were found to inhibit HIV-1 RT with poly(rC)·oligo(dG) as the template primer. The most promising compound in this series was ADAM 3, with EC50 values of 40 nM (vs HIV-1RF) and 20 nM (vs HIV-1IIIB). Compound 3 also inhibited HIV-1 reverse transcriptase with an IC50 of 0.91 μM. ADAM 4 has an antiviral EC50 of 0.6 μM in CEM-SS cells and a plasma half-life of 51.4 min.
DOI: 10.1016/0166-0934(88)90134-6
发表时间: 1988-08-01
影响因子: 3.1
作者:
PAUWELS, R;BALZARINI, J;DECLERCQ, E
通讯作者: DECLERCQ, E
DOI: 10.1021/jm960082v
发表时间: 1996-08-02
影响因子: 7.3
作者:
Cushman, M;Golebiewski, WM;Buckheit, RW
通讯作者: Buckheit, RW
DOI: 10.1021/jm0613121
发表时间: 2007-05-17
影响因子: 7.3
作者:
Herschhorn, Alon;Lerman, Lena;Hizi, Amnon
通讯作者: Hizi, Amnon
DOI: 10.1016/s1054-3589(08)60675-4
发表时间: 1995-01-01
期刊: Advances in pharmacology (San Diego, Calif.)
影响因子: --
作者:
Rice, W G;Bader, J P
通讯作者: Bader, J P
DOI: 10.1002/rcm.1104
发表时间: 2003-01-01
影响因子: 2
作者:
Silvestri, MA;Miles, D;Cushman, M
通讯作者: Cushman, M